BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38320736)

  • 1. Allosteric inhibitor of SHP2 enhances macrophage endocytosis and bacteria elimination by increasing caveolae activation and protects against bacterial sepsis.
    Li T; Xu B; Li W; Cheng X; Tantai W; Zheng H; Zhao L; Li N; Han C
    Pharmacol Res; 2024 Mar; 201():107096. PubMed ID: 38320736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endosomal LAPF is required for macrophage endocytosis and elimination of bacteria.
    Li T; Qin K; Li N; Han C; Cao X
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12958-12963. PubMed ID: 31189603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Toll-like receptor 4 contributes to the internalization and elimination of Escherichia coli in sheep by enhancing caveolae-dependent endocytosis.
    Li Y; Zhao Y; Xu X; Zhang R; Zhang J; Zhang X; Li Y; Deng S; Lian Z
    J Anim Sci Biotechnol; 2021 May; 12(1):63. PubMed ID: 33966642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SHP2 by the Small Molecule Drug SHP099 Prevents Lipopolysaccharide-Induced Acute Lung Injury in Mice.
    Ye S; Zuo B; Xu L; Wu Y; Luo R; Ma L; Yao W; Chen L; Liang G; Zhang Y
    Inflammation; 2023 Jun; 46(3):975-986. PubMed ID: 36732395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice.
    Tsai TH; Chen SF; Huang TY; Tzeng CF; Chiang AS; Kou YR; Lee TS; Shyue SK
    Shock; 2011 Jan; 35(1):92-9. PubMed ID: 20601931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics.
    Gao J; Wu Z; Zhao M; Zhang R; Li M; Sun D; Cheng H; Qi X; Shen Y; Xu Q; Chen H; Chen D; Sun Y
    Acta Pharm Sin B; 2022 Jan; 12(1):149-166. PubMed ID: 35127377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model.
    Jiang J; Hu B; Chung CS; Chen Y; Zhang Y; Tindal EW; Li J; Ayala A
    Mol Med; 2020 Sep; 26(1):89. PubMed ID: 32957908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis.
    Zhu Y; Wu Z; Yan W; Shao F; Ke B; Jiang X; Gao J; Guo W; Lai Y; Ma H; Chen D; Xu Q; Sun Y
    EMBO Mol Med; 2022 Mar; 14(3):e14455. PubMed ID: 34936223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
    Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichinella spiralis cystatin alleviates polymicrobial sepsis through activating regulatory macrophages.
    Li H; Qiu D; Yuan Y; Wang X; Wu F; Yang H; Wang S; Ma M; Qian Y; Zhan B; Yang X
    Int Immunopharmacol; 2022 Aug; 109():108907. PubMed ID: 35691271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose-coated Ångstrom silver prevents sepsis by killing bacteria and attenuating bacterial toxin-induced injuries.
    Yin H; Zhou M; Chen X; Wan TF; Jin L; Rao SS; Tan YJ; Duan R; Zhang Y; Wang ZX; Wang YY; He ZH; Luo MJ; Hu XK; Wang Y; Situ WY; Tang SY; Liu WE; Chen CY; Xie H
    Theranostics; 2021; 11(17):8152-8171. PubMed ID: 34373734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.
    Pfeiffer A; Franciosa G; Locard-Paulet M; Piga I; Reckzeh K; Vemulapalli V; Blacklow SC; Theilgaard-Mönch K; Jensen LJ; Olsen JV
    Cancer Res; 2022 Jun; 82(11):2141-2155. PubMed ID: 35311954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.
    Chen Z; Tang Y; Yu J; Dong R; Yang Y; Fu M; Luo J; Hu S; Wang DW; Tu L; Xu X
    Shock; 2020 Jun; 53(6):761-771. PubMed ID: 31318834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099.
    Tani H; Kurita S; Miyamoto R; Ochiai K; Tamura K; Bonkobara M
    Vet Comp Oncol; 2020 Jun; 18(2):161-168. PubMed ID: 31339650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage SAMSN1 protects against sepsis-induced acute lung injury in mice.
    Jiang W; Ma C; Bai J; Du X
    Redox Biol; 2022 Oct; 56():102432. PubMed ID: 35981417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.
    Ramos-Benitez MJ; Ruiz-Jimenez C; Rosado-Franco JJ; Ramos-Pérez WD; Mendez LB; Osuna A; Espino AM
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30567900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.
    Abbasi M; Gupta VK; Chitranshi N; Gupta V; Ranjbaran R; Rajput R; Pushpitha K; Kb D; You Y; Salekdeh GH; Parton RG; Mirzaei M; Graham SL
    Theranostics; 2021; 11(13):6154-6172. PubMed ID: 33995651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shp2 Deficiency Impairs the Inflammatory Response Against Haemophilus influenzae by Regulating Macrophage Polarization.
    Zhao L; Xia J; Li T; Zhou H; Ouyang W; Hong Z; Ke Y; Qian J; Xu F
    J Infect Dis; 2016 Aug; 214(4):625-33. PubMed ID: 27330052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SHP2 (PTPN11) in glycoprotein VI-dependent thrombus formation: Improved platelet responsiveness by the allosteric drug SHP099 in Noonan syndrome patients.
    Fernández DI; Diender M; Hermida-Nogueira L; Huang J; Veiras S; Henskens YMC; Te Loo MWM; Heemskerk JWM; Kuijpers MJE; García Á
    Thromb Res; 2023 Aug; 228():105-116. PubMed ID: 37302266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2
    Du S; Lu XH; Li WY; Li LP; Ma YC; Zhou L; Wu JW; Ma Y; Wang RL
    Mol Divers; 2021 Aug; 25(3):1873-1887. PubMed ID: 33392964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.